Shanghai Shen Lian Biomedical Corporation's high P/S ratio i...
Shanghai Shen Lian Biomedical Corporation's high P/S ratio is alarming considering its recent revenue drop. Shareholders may face a tough time ahead unless the recent medium-term conditions improve.
Pinning Down Shanghai Shen Lian Biomedical Corporation's (SHSE:688098) P/S Is Difficult Right Now
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4264Followers
0Following
9356Visitors
Follow